Fig. 2From: Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applicationsA diagram of the miRNAs application in clinical trials depended on the available data up to May 2019. Data show the majority of miRNA-related clinical trial belongs to breast cancer. Diseases are presented based on the percentage of the clinical trials deal with miRNAsBack to article page